Actionable news
All posts from Actionable news
Actionable news in OMED: OncoMed Pharmaceuticals, Inc.,

OncoMed Pharmaceuticals' (OMED) CEO Paul Hastings on Q3 2015 Results - Earnings Call Transcript


Good morning, everyone, and welcome to the OncoMed Pharmaceuticals' Third Quarter Investor Conference Call. This call is being recorded. At this time, for opening remarks and introductions, I would like to turn the call over to Michelle Corral, head of OncoMed Investor Relations and Corporate Communications. Ms. Corral, please go ahead.

Michelle Corral - Senior Director of IR and Corporate Communications

Thank you, Liz. Hello, everyone, and welcome to OncoMed Pharmaceuticals' financial results call for the third quarter of 2015. I'm Michelle Corral, Senior Director of Investor Relations and Corporate Communications for OncoMed.

Leading the call today is Paul Hastings, our Chairman and Chief Executive Officer. Paul is joined by Sunil Patel, CFO and SVP of Corporate Development and Finance; Jakob Dupont, Senior Vice President and Chief Medical Officer; and John Lewicki, Executive Vice President and Chief Scientific Officer.

Before we begin, I would like to remind you that during the course of this conference call, management will make a number of forward-looking statements which are statements regarding future events, including the future financial performance of the company. These forward-looking statements...